Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Silver Spike Acquisition Corp. II combination with Eleusis
We are advising the SPAC on the transaction
Smith+Nephew acquisition of Engage Surgical
We are advising Smith+Nephew on the transaction
ProKidney combination with Social Capital Suvretta Holdings Corp. III
We are advising ProKidney on the transaction
Convey Health Solutions acquisition of HealthSmart International
We are advising Convey Health Solutions on the transaction
Signify Health defeats bid for preliminary injunction in trade-secret dispute
We secured a favorable resolution of all claims on behalf of Signify
Biodesix $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Legend Biotech $345 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Dynamics Special Purpose $601 million combination with Senti Biosciences
We are advising Dynamics, a SPAC, on the transaction
BeiGene RMB22.2 billion Shanghai IPO
The offering, equivalent to $3.5 billion, is the largest biotech IPO to date in 2021
Yonghe HK$1.49 billion IPO
The shares are listed on the HKEX